Disbrow Joshua R. 4
4 · AYTU BIOPHARMA, INC · Filed Jun 15, 2023
Insider Transaction Report
Form 4
Disbrow Joshua R.
Chief Executive Officer
Transactions
- Purchase
Common Shares
2023-06-14$1.86/sh+14,000$26,079→ 71,591 total
Footnotes (2)
- [F1]The purchase price reported in Column 4 above is an average weighted price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $1.87, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F2]Reflects a 1:20 reverse stock split effected by the Issuer on January 4, 2023.